0000899243-16-014988.txt : 20160302 0000899243-16-014988.hdr.sgml : 20160302 20160302163327 ACCESSION NUMBER: 0000899243-16-014988 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160301 FILED AS OF DATE: 20160302 DATE AS OF CHANGE: 20160302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 720-940-2200 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keuer Thomas A CENTRAL INDEX KEY: 0001290482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22873 FILM NUMBER: 161477534 MAIL ADDRESS: STREET 1: C/O ARCA BIOPHARMA, INC. STREET 2: 11080 CIRCLEPOINT RD, STE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-01 0 0000907654 ARCA biopharma, Inc. ABIO 0001290482 Keuer Thomas A ARCA BIOPHARMA, INC. 11080 CIRCLEPOINT ROAD, SUITE 140 WESTMINSTER CO 80020 0 1 0 0 Chief Operating Officer Common Stock 2016-03-01 4 S 0 457 3.53 D 16481 D Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan"). Includes (i) remaining 2,143 previously reported shares issued as RSUs under the Plan that vests on 9/17/16, (ii) remaining 1,429 previously reported shares issued as RSUs under the Plan that vests on 10/15/16, (iii) remaining 2,443 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning on 2/27/17, and (iv) 3,621 previously reported shares issued as RSUs under the Plan that vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 6,845 previously reported shares of common stock owned. /s/ Brian L. Selby, Attorney-in-Fact 2016-03-02